Cartesian Therapeutics RNAC
NASDAQ RNAC
$7.36 +0.14 (+1.94%)
At close: Oct 2, 2026 · 4:00 PM EDT

Cartesian Therapeutics (RNAC) Net Preferred Shares Issued and Repurchased (2023 - 2024)

Updated

Cartesian Therapeutics (RNAC) posted Net Preferred Shares Issued and Repurchased of $40 million for FY2024, up 97.5% from $20.25 million in FY2023.

Analysis

Cartesian Therapeutics (RNAC) Net Preferred Shares Issued and Repurchased (2023 - 2024) Analysis & Trends

  • Business Quant data shows RNAC's Net Preferred Shares Issued and Repurchased at $20.25 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Pref. Shares Issued (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Cartesian Therapeutics 221.08 Mn 221.08 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 40.00 Mn
Dec 31, 2023 20.25 Mn
API Access

Cartesian Therapeutics Net Preferred Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-preferred-shares-issued-and-repurchased&ticker=RNAC&period=max&api_key=YOUR_API_KEY